How to Apply for the Bono PAD to Evaluate for Autism Spectrum Disorder in Children and Adolescents
Translated from Spanish, summarized and contextualized by DistantNews.
At a glance
- Chile's Fonasa offers a subsidized evaluation for Autism Spectrum Disorder (TEA) for individuals up to 18 years old.
- The Bono PAD (Programmatic Medical Coverage) covers diagnostic evaluations by a specialized team.
- This benefit is available for Fonasa beneficiaries in tranches B, C, and D.
Chile's National Health Fund (Fonasa) is providing a subsidized evaluation for Autism Spectrum Disorder (TEA) as part of its extensive PAD (Programmatic Medical Coverage) offerings.
This benefit, available for individuals up to 18 years of age, falls under Fonasa's 99 PAD bonuses. It is designed to facilitate access to specific clinical evaluations aimed at detecting TEA. These evaluations encompass a thorough review of medical history, assessment of symptomatology, examination of communication skills, and the formulation of intervention recommendations.
The program is specifically targeted at Fonasa affiliates belonging to tranches B, C, and D. These beneficiaries will receive attention from a multidisciplinary team comprising an occupational therapist, a speech-language pathologist (fonoaudiรณlogo), and a psychologist, all of whom possess specialized expertise in child development and TEA.
The inclusion of TEA evaluations within the PAD program signifies an effort to improve early detection and intervention for neurodevelopmental disorders in young Chileans. By offering these specialized services at a subsidized rate, Fonasa aims to make crucial diagnostic processes more accessible to a broader segment of the population.
Originally published by BioBioChile in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.